xCures Releases xDECIDE Platform to Personalize Cancer Care Using RWD

November 26, 2021

Released earlier this month, the xDECIDE platform helps doctors choose the optimal treatment strategy for cancer patients, according to a press release from xCures. The consolidated online platform uses real-world data (RWD), expert recommendations, and an advanced learning network to provide a ranked list of treatment options tailored to a patient’s individual case details. This service is provided free of cost to providers and patients.

According to xCures, “A patient’s Treatment Options Report is generated through a combination of xCures’ technology, overseen by an expert team of Ph.D. scientists. It takes into account patient features, a broad set of patient outcomes data, expert recommendations, and insights from virtual tumor boards, public data sources, and an active learning network. Through xDECIDE, providers also have an opportunity to contribute to the refinement of xCures’ technology by making treatment decisions that feedback into xCures’ ever-growing knowledge base.”